GlycoMimetics Inc (GLYC)
1.75
-0.10
(-5.66%)
USD |
NASDAQ |
Apr 25, 10:18
GlycoMimetics Cash from Investing (TTM): -0.0214M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.0214M |
September 30, 2023 | -0.0206M |
June 30, 2023 | -0.0152M |
March 31, 2023 | -0.0459M |
December 31, 2022 | -0.0842M |
September 30, 2022 | -0.0866M |
June 30, 2022 | -0.0885M |
March 31, 2022 | -0.0524M |
December 31, 2021 | -0.0149M |
September 30, 2021 | -0.0507M |
June 30, 2021 | -0.0622M |
March 31, 2021 | -0.0634M |
December 31, 2020 | -0.0685M |
September 30, 2020 | -0.0427M |
June 30, 2020 | -0.0451M |
March 31, 2020 | -0.1135M |
December 31, 2019 | -0.1449M |
September 30, 2019 | -0.1896M |
June 30, 2019 | -0.1979M |
March 31, 2019 | -0.1485M |
December 31, 2018 | -0.1256M |
Date | Value |
---|---|
September 30, 2018 | -0.1029M |
June 30, 2018 | -0.109M |
March 31, 2018 | -0.2478M |
December 31, 2017 | -0.2941M |
September 30, 2017 | -0.6984M |
June 30, 2017 | -0.8911M |
March 31, 2017 | -0.7499M |
December 31, 2016 | -0.7042M |
September 30, 2016 | -0.2689M |
June 30, 2016 | -0.1019M |
March 31, 2016 | -0.2835M |
December 31, 2015 | -0.2686M |
September 30, 2015 | -0.2802M |
June 30, 2015 | -0.3238M |
March 31, 2015 | -0.201M |
December 31, 2014 | -0.2126M |
September 30, 2014 | -0.2102M |
June 30, 2014 | -0.1473M |
March 31, 2014 | -0.0892M |
December 31, 2013 | -0.0821M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.1979M
Minimum
Jun 2019
-0.0149M
Maximum
Dec 2021
-0.0741M
Average
-0.0622M
Median
Jun 2021
Cash from Investing (TTM) Benchmarks
Altimmune Inc | 13.73M |
Cellectar Biosciences Inc | -0.864M |
PDS Biotechnology Corp | -- |
Syros Pharmaceuticals Inc | 37.34M |
Precision BioSciences Inc | 5.829M |